Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Amicus Therapeutics, Inc. (FOLD) had Debt to Capital Ratio of 0.59 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$185.21M |
|
$1.69M |
|
$26.55M |
|
$158.66M |
|
$169.27M |
|
$15.95M |
|
$-12.80M |
|
$3.14M |
|
$3.14M |
|
$1.69M |
|
$1.69M |
|
$1.69M |
|
$1.69M |
|
$15.95M |
|
$18.52M |
|
308.36M |
|
308.36M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$676.17M |
|
$27.11M |
|
$273.70M |
|
$949.87M |
|
$237.83M |
|
$392.66M |
|
$437.80M |
|
$675.63M |
|
$274.24M |
|
$62.53M |
|
$274.24M |
|
310.85M |
|
| Cash Flow Statement Financials | |
$33.15M |
|
$-46.43M |
|
$0.61M |
|
$216.72M |
|
$217.32M |
|
$0.60M |
|
$87.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.84 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.59 |
1.43 |
|
85.67% |
|
8.61% |
|
8.61% |
|
-- |
|
1.70% |
|
0.91% |
|
$29.85M |
|
-- |
|
-- |
|
-- |
|
0.20 |
|
0.12 |
|
1.61 |
|
56.03 |
|
0.62% |
|
2.70% |
|
0.18% |
|
0.25% |
|
$0.88 |
|
$0.10 |
|
$0.11 |
|